Daniel Golightly
Addiction Medicine · Smyrna, GANPI 1508955071
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.3% of the total. Among addiction medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$459
- Takeda Pharmaceuticals U.S.A., Inc.$242
- Sunovion Pharmaceuticals Inc.$239
- Teva Pharmaceuticals USA, Inc.$172
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$168
- Lundbeck LLC$123
- plus $482 from 13 others
What the payments were for
- Food & beverage$1,78995%
- Education$965%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $459 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $242 |
| Sunovion Pharmaceuticals Inc. | 12 | $239 |
| Teva Pharmaceuticals USA, Inc. | 11 | $172 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $168 |
| Lundbeck LLC | 6 | $123 |
| Orexo US, Inc. | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Alkermes, Inc. | 2 | $42 |
| Bausch Health US, LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Eisai Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYVANSE$125
How this compares
$1,886 in reported general payments places this provider in the 90th percentile of 35 addiction medicine providers in Georgia.
Other addiction medicine in Smyrna
- Kimberlynn RichardsSmyrna$14K
- Tommie RichardsonSmyrna$14K
- Derek KlemmDemorest$5K
- Scott MilesSt.mary's$887
- Roy AryAtlanta$749
- Ajibola BabatundeAcworth$549
- Patrice MarshallDecatur$453
- Stacy SeikelDahlonega$414
- Claire TuckerStatesboro$352
- Sabrina HannaDahlonega$271
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.